Tag: Venetoclax

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Venetoclax

AbbVie - Roche's Venclexta Receives Breakthrough Therapy Tag In High-Risk Myelodysplastic ...

Added to Collection on: 2021-07-21 09:45:00

Tags for this article:

Chemical compounds
Health sciences
Health care
Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Chloroarenes
Monoclonal antibodies
Venetoclax
AbbVie
Hoffmann-La Roche
Emicizumab

Click the tags to see associated articles and topics

View Article Details
Real-World Data Shows Higher Incidence of Neutropenia With Venetoclax, Obinutuzumab Combo ...

Added to Collection on: 2021-07-22 20:26:15

Tags for this article:

Chemical compounds
Drugs
Health care
Breakthrough therapy
Orphan drugs
Benzamides
Chloroarenes
Venetoclax
Chronic lymphocytic leukemia
Neutropenia
Obinutuzumab
Rituximab

Click the tags to see associated articles and topics

View Article Details
Relapsed and Refractory Follicular Lymphoma

Added to Collection on: 2021-07-29 13:18:45

Tags for this article:

Chemical compounds
Drugs
Clinical medicine
Orphan drugs
Antineoplastic drugs
Breakthrough therapy
Non-Hodgkin lymphoma
Lymphoma
Copanlisib
Chemotherapy regimen
Indolent lymphoma
Venetoclax
Rituximab

Click the tags to see associated articles and topics

View Article Details
Understanding the Management of CLL in the Time of COVID-19

Added to Collection on: 2021-07-30 17:03:45

Tags for this article:

Chemical compounds
Clinical medicine
Medicine
Antineoplastic drugs
Chronic lymphocytic leukemia
Breakthrough therapy
Orphan drugs
Hypogammaglobulinemia
Venetoclax
Immunoglobulin therapy
Leukemia
Monoclonal B-cell lymphocytosis

Click the tags to see associated articles and topics

View Article Details
How Well Does the COVID-19 Vaccine Work If You Have CLL?

Added to Collection on: 2021-08-11 19:01:25

Tags for this article:

Chemical compounds
Health care
Medicine
Chronic lymphocytic leukemia
Orphan drugs
Antineoplastic drugs
Vaccine
COVID-19 vaccine
Venetoclax
Vaccination
Leukemia
Monoclonal B-cell lymphocytosis

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Cancer Trial Hit with Clinical Hold Following Cardiac Issues

Added to Collection on: 2021-10-22 05:15:11

Tags for this article:

Chemical compounds
Health sciences
Health care
Antineoplastic drugs
Benzamides
Chloroarenes
Sulfonamides
Venetoclax
Amgen
Acute myeloid leukemia
AstraZeneca
Oxford–AstraZeneca COVID-19 vaccine

Click the tags to see associated articles and topics

View Article Details
New Data from Phase 3 GLOW Study Show Fixed-Duration Treatment with IMBRUVICA ...

Added to Collection on: 2021-12-12 05:01:14

Tags for this article:

Chemical compounds
Health sciences
Health
Breakthrough therapy
Orphan drugs
Non-Hodgkin lymphoma
Lymphoma
Tyrosine kinase inhibitors
Ibrutinib
Venetoclax
Chronic lymphocytic leukemia
Mantle cell lymphoma
Johnson & Johnson
Arnon Kater
PCI-32765
IMBRUVICA
Johnson & Johnson's
Obinutuzumab
janssen pharmaceutical

Click the tags to see associated articles and topics

View Article Details
Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for ...

Added to Collection on: 2021-12-12 21:05:06

Tags for this article:

Chemical compounds
Branches of biology
Organic compounds
Orphan drugs
Peripheral membrane proteins
Breakthrough therapy
Antineoplastic drugs
Bruton's tyrosine kinase
Chronic lymphocytic leukemia
Mantle cell lymphoma
Phosphoinositide 3-kinase inhibitor
Venetoclax
the university of texas md anderson cancer center

Click the tags to see associated articles and topics

View Article Details
Ibrutinib/Venetoclax Bests Chlorambucil/Obinutuzumab for Treating CLL

Added to Collection on: 2021-12-26 17:09:13

Tags for this article:

Chemical compounds
Organic compounds
Drugs
Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Tyrosine kinase inhibitors
Chloroarenes
Venetoclax
Chronic lymphocytic leukemia
Obinutuzumab
Ibrutinib

Click the tags to see associated articles and topics

View Article Details
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall

Added to Collection on: 2024-02-02 18:21:42

Tags for this article:

Orphan drugs
AbbVie
Cerevel Therapeutics
ImmunoGen
Benzinga
Ibrutinib
Venetoclax
NASDAQ
Adalimumab
AbbVie Inc.

Click the tags to see associated articles and topics

View Article Details